Bruce Loveland
Head of Research Support & Facilities
Life Sciences
Burnet Institute
Australia
Biography
Bruce Loveland is a cellular immunologist interested in the immune repertoire and how immune responses develop, are expressed and change. He has focused on studies of immune effector cells and the underlying genetic, molecular and physiological basis of immunity in organ transplantation, autoimmunity and viral immune responses. His career experience includes working at Melbourne University (PhD 1981), in London (MRC Clinical Research Centre, Harrow), Dallas (Howard Hughes Institute) and returning to Monash University, the Austin Research Institute (as NHMRC Senior Research Fellow, 1996-2004) and Burnet Institute.
Research Interest
Bruce has extensive experience in project and facilities management, cGLP and cGMP requirements, and in translational medical research with technical transfer from research laboratory to clinical trials, particularly for xenotransplantation and for cellular immunotherapies with Phase I and II clinical trials for cancer and persistent hepatitis C infection.
Publications
-
Update on Mucin-1 immunotherapy in cancer: a clinical perspective. Rivalland G, Loveland B, Mitchell P Expert Opin Biol Ther. 2015 Oct; 15(12):1773-1787
-
An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment. Klein B, Schuppe HC, Bergmann M, Hedger MP, Loveland BE, Loveland KL Andrology. 2017 May; 5(4):763-770
-
Cytokines in male fertility and reproductive pathologies: immunoregulation and beyond. Loveland KL, Klein B, Pueschi D, Indumathy S, Bergmann M, Loveland BE, Hedger MP, Schuppe H Front Endocrin. 2017 Nov; 8:307
